APO Research
Talk to an analyst

APO RESEARCH · REPORT

Apatinib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Apatinib Market Analysis and Forecast 2026-2032

23 December 2025197 pages

Choose your research edition.

Industry ResearchApatinib Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Apatinib Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Apatinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Apatinib Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Apatinib Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Apatinib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Apatinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Apatinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Apatinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Apatinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Apatinib include Jiangsu Hengrui Medicine, LSK BioPartners, Bukwang Pharmaceutical Company and Advenchen Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Apatinib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Apatinib, also provides the sales of main regions and countries. Of the upcoming market potential for Apatinib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Apatinib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Apatinib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Apatinib sales, projected growth trends, production technology, application and end-user industry.

Apatinib Segment by Company

Jiangsu Hengrui Medicine

LSK BioPartners

Bukwang Pharmaceutical Company

Advenchen Laboratories

Apatinib Segment by Type

0.25g/Pcs

0.425g/Pcs

0.375g/Pcs

Apatinib Segment by Application

Advanced Hepatocellular Carcinoma

Metastatic Breast Cancer

Metastatic Gastric Carcinoma

Others

Apatinib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Apatinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Apatinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Apatinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Apatinib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Apatinib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Apatinib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Apatinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 0.25g/Pcs Major Manufacturers Table 3. 0.425g/Pcs Major Manufacturers Table 4. 0.375g/Pcs Major Manufacturers Table 5. Global Apatinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Advanced Hepatocellular Carcinoma Major Manufacturers Table 7. Metastatic Breast Cancer Major Manufacturers Table 8. Metastatic Gastric Carcinoma Major Manufacturers Table 9. Others Major Manufacturers Table 10. Apatinib Industry Trends Table 11. Apatinib Industry Drivers Table 12. Apatinib Industry Opportunities and Challenges Table 13. Apatinib Industry Restraints Table 14. Global Apatinib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Apatinib Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Apatinib Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Apatinib Revenue Market Share by Region (2021-2026) Table 18. Global Apatinib Revenue Market Share by Region (2027-2032) Table 19. Global Apatinib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k pcs) Table 20. Global Apatinib Sales by Region (2021-2026) & (k pcs) Table 21. Global Apatinib Sales by Region (2027-2032) & (k pcs) Table 22. Global Apatinib Sales Market Share by Region (2021-2026) Table 23. Global Apatinib Sales Market Share by Region (2027-2032) Table 24. Global Apatinib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Apatinib Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Apatinib Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Apatinib Sales Market Share by Manufacturers (2021-2026) Table 28. Global Apatinib Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 29. Global Apatinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Apatinib Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Apatinib Manufacturers, Product Type & Application Table 32. Global Apatinib Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Apatinib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Apatinib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Apatinib Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Apatinib Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Apatinib Revenue Market Share by Type (2021-2026) Table 39. Global Apatinib Revenue Market Share by Type (2027-2032) Table 40. Global Apatinib Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 41. Global Apatinib Sales by Type (2021-2026) & (k pcs) Table 42. Global Apatinib Sales by Type (2027-2032) & (k pcs) Table 43. Global Apatinib Sales Market Share by Type (2021-2026) Table 44. Global Apatinib Sales Market Share by Type (2027-2032) Table 45. Global Apatinib Price by Type (2021-2026) & (US$/pcs) Table 46. Global Apatinib Price by Type (2027-2032) & (US$/pcs) Table 47. Global Apatinib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Apatinib Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Apatinib Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Apatinib Revenue Market Share by Application (2021-2026) Table 51. Global Apatinib Revenue Market Share by Application (2027-2032) Table 52. Global Apatinib Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 53. Global Apatinib Sales by Application (2021-2026) & (k pcs) Table 54. Global Apatinib Sales by Application (2027-2032) & (k pcs) Table 55. Global Apatinib Sales Market Share by Application (2021-2026) Table 56. Global Apatinib Sales Market Share by Application (2027-2032) Table 57. Global Apatinib Price by Application (2021-2026) & (US$/pcs) Table 58. Global Apatinib Price by Application (2027-2032) & (US$/pcs) Table 59. Jiangsu Hengrui Medicine Company Information Table 60. Jiangsu Hengrui Medicine Business Overview Table 61. Jiangsu Hengrui Medicine Apatinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 62. Jiangsu Hengrui Medicine Apatinib Product Portfolio Table 63. Jiangsu Hengrui Medicine Recent Development Table 64. LSK BioPartners Company Information Table 65. LSK BioPartners Business Overview Table 66. LSK BioPartners Apatinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 67. LSK BioPartners Apatinib Product Portfolio Table 68. LSK BioPartners Recent Development Table 69. Bukwang Pharmaceutical Company Company Information Table 70. Bukwang Pharmaceutical Company Business Overview Table 71. Bukwang Pharmaceutical Company Apatinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 72. Bukwang Pharmaceutical Company Apatinib Product Portfolio Table 73. Bukwang Pharmaceutical Company Recent Development Table 74. Advenchen Laboratories Company Information Table 75. Advenchen Laboratories Business Overview Table 76. Advenchen Laboratories Apatinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 77. Advenchen Laboratories Apatinib Product Portfolio Table 78. Advenchen Laboratories Recent Development Table 79. North America Apatinib Revenue by Type (2021-2026) & (US$ Million) Table 80. North America Apatinib Revenue by Type (2027-2032) & (US$ Million) Table 81. North America Apatinib Sales by Type (2021-2026) & (k pcs) Table 82. North America Apatinib Sales by Type (2027-2032) & (k pcs) Table 83. North America Apatinib Sales Price by Type (2021-2026) & (US$/pcs) Table 84. North America Apatinib Sales Price by Type (2027-2032) & (US$/pcs) Table 85. North America Apatinib Revenue by Application (2021-2026) & (US$ Million) Table 86. North America Apatinib Revenue by Application (2027-2032) & (US$ Million) Table 87. North America Apatinib Sales by Application (2021-2026) & (k pcs) Table 88. North America Apatinib Sales by Application (2027-2032) & (k pcs) Table 89. North America Apatinib Sales Price by Application (2021-2026) & (US$/pcs) Table 90. North America Apatinib Sales Price by Application (2027-2032) & (US$/pcs) Table 91. North America Apatinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Apatinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 93. North America Apatinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 94. North America Apatinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 95. North America Apatinib Sales by Country (2021-2026) & (k pcs) Table 96. North America Apatinib Sales by Country (2027-2032) & (k pcs) Table 97. North America Apatinib Sales Price by Country (2021-2026) & (US$/pcs) Table 98. North America Apatinib Sales Price by Country (2027-2032) & (US$/pcs) Table 99. United States Apatinib Revenue (2021-2032) & (US$ Million) Table 100. Canada Apatinib Revenue (2021-2032) & (US$ Million) Table 101. Mexico Apatinib Revenue (2021-2032) & (US$ Million) Table 102. Europe Apatinib Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe Apatinib Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe Apatinib Sales by Type (2021-2026) & (k pcs) Table 105. Europe Apatinib Sales by Type (2027-2032) & (k pcs) Table 106. Europe Apatinib Sales Price by Type (2021-2026) & (US$/pcs) Table 107. Europe Apatinib Sales Price by Type (2027-2032) & (US$/pcs) Table 108. Europe Apatinib Revenue by Application (2021-2026) & (US$ Million) Table 109. Europe Apatinib Revenue by Application (2027-2032) & (US$ Million) Table 110. Europe Apatinib Sales by Application (2021-2026) & (k pcs) Table 111. Europe Apatinib Sales by Application (2027-2032) & (k pcs) Table 112. Europe Apatinib Sales Price by Application (2021-2026) & (US$/pcs) Table 113. Europe Apatinib Sales Price by Application (2027-2032) & (US$/pcs) Table 114. Europe Apatinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Europe Apatinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. Europe Apatinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. Europe Apatinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 118. Europe Apatinib Sales by Country (2021-2026) & (k pcs) Table 119. Europe Apatinib Sales by Country (2027-2032) & (k pcs) Table 120. Europe Apatinib Sales Price by Country (2021-2026) & (US$/pcs) Table 121. Europe Apatinib Sales Price by Country (2027-2032) & (US$/pcs) Table 122. Germany Apatinib Revenue (2021-2032) & (US$ Million) Table 123. France Apatinib Revenue (2021-2032) & (US$ Million) Table 124. U.K. Apatinib Revenue (2021-2032) & (US$ Million) Table 125. Italy Apatinib Revenue (2021-2032) & (US$ Million) Table 126. Russia Apatinib Revenue (2021-2032) & (US$ Million) Table 127. Spain Apatinib Revenue (2021-2032) & (US$ Million) Table 128. Netherlands Apatinib Revenue (2021-2032) & (US$ Million) Table 129. Switzerland Apatinib Revenue (2021-2032) & (US$ Million) Table 130. Sweden Apatinib Revenue (2021-2032) & (US$ Million) Table 131. Poland Apatinib Revenue (2021-2032) & (US$ Million) Table 132. China Apatinib Revenue by Type (2021-2026) & (US$ Million) Table 133. China Apatinib Revenue by Type (2027-2032) & (US$ Million) Table 134. China Apatinib Sales by Type (2021-2026) & (k pcs) Table 135. China Apatinib Sales by Type (2027-2032) & (k pcs) Table 136. China Apatinib Sales Price by Type (2021-2026) & (US$/pcs) Table 137. China Apatinib Sales Price by Type (2027-2032) & (US$/pcs) Table 138. China Apatinib Revenue by Application (2021-2026) & (US$ Million) Table 139. China Apatinib Revenue by Application (2027-2032) & (US$ Million) Table 140. China Apatinib Sales by Application (2021-2026) & (k pcs) Table 141. China Apatinib Sales by Application (2027-2032) & (k pcs) Table 142. China Apatinib Sales Price by Application (2021-2026) & (US$/pcs) Table 143. China Apatinib Sales Price by Application (2027-2032) & (US$/pcs) Table 144. Asia Apatinib Revenue by Type (2021-2026) & (US$ Million) Table 145. Asia Apatinib Revenue by Type (2027-2032) & (US$ Million) Table 146. Asia Apatinib Sales by Type (2021-2026) & (k pcs) Table 147. Asia Apatinib Sales by Type (2027-2032) & (k pcs) Table 148. Asia Apatinib Sales Price by Type (2021-2026) & (US$/pcs) Table 149. Asia Apatinib Sales Price by Type (2027-2032) & (US$/pcs) Table 150. Asia Apatinib Revenue by Application (2021-2026) & (US$ Million) Table 151. Asia Apatinib Revenue by Application (2027-2032) & (US$ Million) Table 152. Asia Apatinib Sales by Application (2021-2026) & (k pcs) Table 153. Asia Apatinib Sales by Application (2027-2032) & (k pcs) Table 154. Asia Apatinib Sales Price by Application (2021-2026) & (US$/pcs) Table 155. Asia Apatinib Sales Price by Application (2027-2032) & (US$/pcs) Table 156. Asia Apatinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Asia Apatinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. Asia Apatinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. Asia Apatinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 160. Asia Apatinib Sales by Country (2021-2026) & (k pcs) Table 161. Asia Apatinib Sales by Country (2027-2032) & (k pcs) Table 162. Asia Apatinib Sales Price by Country (2021-2026) & (US$/pcs) Table 163. Asia Apatinib Sales Price by Country (2027-2032) & (US$/pcs) Table 164. Japan Apatinib Revenue (2021-2032) & (US$ Million) Table 165. South Korea Apatinib Revenue (2021-2032) & (US$ Million) Table 166. India Apatinib Revenue (2021-2032) & (US$ Million) Table 167. Australia Apatinib Revenue (2021-2032) & (US$ Million) Table 168. Taiwan Apatinib Revenue (2021-2032) & (US$ Million) Table 169. Southeast Asia Apatinib Revenue (2021-2032) & (US$ Million) Table 170. SAMEA Apatinib Revenue by Type (2021-2026) & (US$ Million) Table 171. SAMEA Apatinib Revenue by Type (2027-2032) & (US$ Million) Table 172. SAMEA Apatinib Sales by Type (2021-2026) & (k pcs) Table 173. SAMEA Apatinib Sales by Type (2027-2032) & (k pcs) Table 174. SAMEA Apatinib Sales Price by Type (2021-2026) & (US$/pcs) Table 175. SAMEA Apatinib Sales Price by Type (2027-2032) & (US$/pcs) Table 176. SAMEA Apatinib Revenue by Application (2021-2026) & (US$ Million) Table 177. SAMEA Apatinib Revenue by Application (2027-2032) & (US$ Million) Table 178. SAMEA Apatinib Sales by Application (2021-2026) & (k pcs) Table 179. SAMEA Apatinib Sales by Application (2027-2032) & (k pcs) Table 180. SAMEA Apatinib Sales Price by Application (2021-2026) & (US$/pcs) Table 181. SAMEA Apatinib Sales Price by Application (2027-2032) & (US$/pcs) Table 182. SAMEA Apatinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. SAMEA Apatinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. SAMEA Apatinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. SAMEA Apatinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 186. SAMEA Apatinib Sales by Country (2021-2026) & (k pcs) Table 187. SAMEA Apatinib Sales by Country (2027-2032) & (k pcs) Table 188. SAMEA Apatinib Sales Price by Country (2021-2026) & (US$/pcs) Table 189. SAMEA Apatinib Sales Price by Country (2027-2032) & (US$/pcs) Table 190. Brazil Apatinib Revenue (2021-2032) & (US$ Million) Table 191. Argentina Apatinib Revenue (2021-2032) & (US$ Million) Table 192. Chile Apatinib Revenue (2021-2032) & (US$ Million) Table 193. Colombia Apatinib Revenue (2021-2032) & (US$ Million) Table 194. Peru Apatinib Revenue (2021-2032) & (US$ Million) Table 195. Saudi Arabia Apatinib Revenue (2021-2032) & (US$ Million) Table 196. Israel Apatinib Revenue (2021-2032) & (US$ Million) Table 197. UAE Apatinib Revenue (2021-2032) & (US$ Million) Table 198. Turkey Apatinib Revenue (2021-2032) & (US$ Million) Table 199. Iran Apatinib Revenue (2021-2032) & (US$ Million) Table 200. Egypt Apatinib Revenue (2021-2032) & (US$ Million) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Apatinib Distributors List Table 204. Apatinib Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Apatinib Image Figure 2. Global Apatinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Apatinib Market Size Share 2021 VS 2025 VS 2032 Figure 4. 0.25g/Pcs Image Figure 5. 0.425g/Pcs Image Figure 6. 0.375g/Pcs Image Figure 7. Global Apatinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Apatinib Market Size Share 2021 VS 2025 VS 2032 Figure 9. Advanced Hepatocellular Carcinoma Image Figure 10. Metastatic Breast Cancer Image Figure 11. Metastatic Gastric Carcinoma Image Figure 12. Others Image Figure 13. Global Apatinib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Apatinib Revenue (2021-2032) & (US$ Million) Figure 15. Global Apatinib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Apatinib Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Apatinib Revenue Market Share by Region (2021-2032) Figure 18. Global Apatinib Sales (2021-2032) & (k pcs) Figure 19. Global Apatinib Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 20. Global Apatinib Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Apatinib Sales YoY (2021-2032) & (k pcs) Figure 22. Europe Apatinib Sales YoY (2021-2032) & (k pcs) Figure 23. China Apatinib Sales YoY (2021-2032) & (k pcs) Figure 24. Asia (Excluding China) Apatinib Sales YoY (2021-2032) & (k pcs) Figure 25. South America, Middle East and Africa Apatinib Sales YoY (2021-2032) & (k pcs) Figure 26. Global Apatinib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Apatinib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Apatinib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Apatinib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Apatinib Revenue Market Share by Type (2021-2032) Figure 32. Global Apatinib Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 33. Global Apatinib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Apatinib Sales Market Share by Type (2021-2032) Figure 35. Global Apatinib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Apatinib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Apatinib Revenue Market Share by Application (2021-2032) Figure 38. Global Apatinib Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 39. Global Apatinib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Apatinib Sales Market Share by Application (2021-2032) Figure 41. North America Apatinib Revenue Share by Type (2021-2032) Figure 42. North America Apatinib Sales Share by Type (2021-2032) Figure 43. North America Apatinib Revenue Share by Application (2021-2032) Figure 44. North America Apatinib Sales Share by Application (2021-2032) Figure 45. North America Apatinib Revenue Share by Country (2021-2032) Figure 46. North America Apatinib Sales Share by Country (2021-2032) Figure 47. Europe Apatinib Revenue Share by Type (2021-2032) Figure 48. Europe Apatinib Sales Share by Type (2021-2032) Figure 49. Europe Apatinib Revenue Share by Application (2021-2032) Figure 50. Europe Apatinib Sales Share by Application (2021-2032) Figure 51. Europe Apatinib Revenue Share by Country (2021-2032) Figure 52. Europe Apatinib Sales Share by Country (2021-2032) Figure 53. China Apatinib Revenue Share by Type (2021-2032) Figure 54. China Apatinib Sales Share by Type (2021-2032) Figure 55. China Apatinib Revenue Share by Application (2021-2032) Figure 56. China Apatinib Sales Share by Application (2021-2032) Figure 57. Asia Apatinib Revenue Share by Type (2021-2032) Figure 58. Asia Apatinib Sales Share by Type (2021-2032) Figure 59. Asia Apatinib Revenue Share by Application (2021-2032) Figure 60. Asia Apatinib Sales Share by Application (2021-2032) Figure 61. Asia Apatinib Revenue Share by Country (2021-2032) Figure 62. Asia Apatinib Sales Share by Country (2021-2032) Figure 63. SAMEA Apatinib Revenue Share by Type (2021-2032) Figure 64. SAMEA Apatinib Sales Share by Type (2021-2032) Figure 65. SAMEA Apatinib Revenue Share by Application (2021-2032) Figure 66. SAMEA Apatinib Sales Share by Application (2021-2032) Figure 67. SAMEA Apatinib Revenue Share by Country (2021-2032) Figure 68. SAMEA Apatinib Sales Share by Country (2021-2032) Figure 69. Apatinib Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Apatinib Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 0.25g/Pcs
  • 0.425g/Pcs
  • 0.375g/Pcs
Applications
  • Advanced Hepatocellular Carcinoma
  • Metastatic Breast Cancer
  • Metastatic Gastric Carcinoma
  • Others
Companies covered
  • Jiangsu Hengrui Medicine
  • LSK BioPartners
  • Bukwang Pharmaceutical Company
  • Advenchen Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Apatinib Market by Type
  3. 1.2.1 Global Apatinib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 0.25g/Pcs
  5. 1.2.3 0.425g/Pcs
  6. 1.2.4 0.375g/Pcs
  7. 1.3 Apatinib Market by Application
  8. 1.3.1 Global Apatinib Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Advanced Hepatocellular Carcinoma
  10. 1.3.3 Metastatic Breast Cancer
  11. 1.3.4 Metastatic Gastric Carcinoma
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Apatinib Market Dynamics
  1. 2.1 Apatinib Industry Trends
  2. 2.2 Apatinib Industry Drivers
  3. 2.3 Apatinib Industry Opportunities and Challenges
  4. 2.4 Apatinib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Apatinib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Apatinib Revenue by Region
  3. 3.2.1 Global Apatinib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Apatinib Revenue by Region (2021-2026)
  5. 3.2.3 Global Apatinib Revenue by Region (2027-2032)
  6. 3.2.4 Global Apatinib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Apatinib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Apatinib Sales by Region
  9. 3.4.1 Global Apatinib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Apatinib Sales by Region (2021-2026)
  11. 3.4.3 Global Apatinib Sales by Region (2027-2032)
  12. 3.4.4 Global Apatinib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Apatinib Revenue by Manufacturers
  2. 4.1.1 Global Apatinib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Apatinib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Apatinib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Apatinib Sales by Manufacturers
  6. 4.2.1 Global Apatinib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Apatinib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Apatinib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Apatinib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Apatinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Apatinib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Apatinib Manufacturers, Product Type & Application
  13. 4.7 Global Apatinib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Apatinib Market CR5 and HHI
  16. 4.8.2 2025 Apatinib Tier 1, Tier 2, and Tier 3
5 Apatinib Market by Type
  1. 5.1 Global Apatinib Revenue by Type
  2. 5.1.1 Global Apatinib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Apatinib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Apatinib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Apatinib Sales by Type
  6. 5.2.1 Global Apatinib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Apatinib Sales by Type (2021-2032) & (k pcs)
  8. 5.2.3 Global Apatinib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Apatinib Price by Type
6 Apatinib Market by Application
  1. 6.1 Global Apatinib Revenue by Application
  2. 6.1.1 Global Apatinib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Apatinib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Apatinib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Apatinib Sales by Application
  6. 6.2.1 Global Apatinib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Apatinib Sales by Application (2021-2032) & (k pcs)
  8. 6.2.3 Global Apatinib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Apatinib Price by Application
7 Company Profiles
  1. 7.1 Jiangsu Hengrui Medicine
  2. 7.1.1 Jiangsu Hengrui Medicine Company Information
  3. 7.1.2 Jiangsu Hengrui Medicine Business Overview
  4. 7.1.3 Jiangsu Hengrui Medicine Apatinib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Jiangsu Hengrui Medicine Apatinib Product Portfolio
  6. 7.1.5 Jiangsu Hengrui Medicine Recent Developments
  7. 7.2 LSK BioPartners
  8. 7.2.1 LSK BioPartners Company Information
  9. 7.2.2 LSK BioPartners Business Overview
  10. 7.2.3 LSK BioPartners Apatinib Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 LSK BioPartners Apatinib Product Portfolio
  12. 7.2.5 LSK BioPartners Recent Developments
  13. 7.3 Bukwang Pharmaceutical Company
  14. 7.3.1 Bukwang Pharmaceutical Company Company Information
  15. 7.3.2 Bukwang Pharmaceutical Company Business Overview
  16. 7.3.3 Bukwang Pharmaceutical Company Apatinib Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bukwang Pharmaceutical Company Apatinib Product Portfolio
  18. 7.3.5 Bukwang Pharmaceutical Company Recent Developments
  19. 7.4 Advenchen Laboratories
  20. 7.4.1 Advenchen Laboratories Company Information
  21. 7.4.2 Advenchen Laboratories Business Overview
  22. 7.4.3 Advenchen Laboratories Apatinib Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Advenchen Laboratories Apatinib Product Portfolio
  24. 7.4.5 Advenchen Laboratories Recent Developments
8 North America
  1. 8.1 North America Apatinib Market Size by Type
  2. 8.1.1 North America Apatinib Revenue by Type (2021-2032)
  3. 8.1.2 North America Apatinib Sales by Type (2021-2032)
  4. 8.1.3 North America Apatinib Price by Type (2021-2032)
  5. 8.2 North America Apatinib Market Size by Application
  6. 8.2.1 North America Apatinib Revenue by Application (2021-2032)
  7. 8.2.2 North America Apatinib Sales by Application (2021-2032)
  8. 8.2.3 North America Apatinib Price by Application (2021-2032)
  9. 8.3 North America Apatinib Market Size by Country
  10. 8.3.1 North America Apatinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Apatinib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Apatinib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Apatinib Market Size by Type
  2. 9.1.1 Europe Apatinib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Apatinib Sales by Type (2021-2032)
  4. 9.1.3 Europe Apatinib Price by Type (2021-2032)
  5. 9.2 Europe Apatinib Market Size by Application
  6. 9.2.1 Europe Apatinib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Apatinib Sales by Application (2021-2032)
  8. 9.2.3 Europe Apatinib Price by Application (2021-2032)
  9. 9.3 Europe Apatinib Market Size by Country
  10. 9.3.1 Europe Apatinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Apatinib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Apatinib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Apatinib Market Size by Type
  2. 10.1.1 China Apatinib Revenue by Type (2021-2032)
  3. 10.1.2 China Apatinib Sales by Type (2021-2032)
  4. 10.1.3 China Apatinib Price by Type (2021-2032)
  5. 10.2 China Apatinib Market Size by Application
  6. 10.2.1 China Apatinib Revenue by Application (2021-2032)
  7. 10.2.2 China Apatinib Sales by Application (2021-2032)
  8. 10.2.3 China Apatinib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Apatinib Market Size by Type
  2. 11.1.1 Asia Apatinib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Apatinib Sales by Type (2021-2032)
  4. 11.1.3 Asia Apatinib Price by Type (2021-2032)
  5. 11.2 Asia Apatinib Market Size by Application
  6. 11.2.1 Asia Apatinib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Apatinib Sales by Application (2021-2032)
  8. 11.2.3 Asia Apatinib Price by Application (2021-2032)
  9. 11.3 Asia Apatinib Market Size by Country
  10. 11.3.1 Asia Apatinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Apatinib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Apatinib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Apatinib Market Size by Type
  2. 12.1.1 SAMEA Apatinib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Apatinib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Apatinib Price by Type (2021-2032)
  5. 12.2 SAMEA Apatinib Market Size by Application
  6. 12.2.1 SAMEA Apatinib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Apatinib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Apatinib Price by Application (2021-2032)
  9. 12.3 SAMEA Apatinib Market Size by Country
  10. 12.3.1 SAMEA Apatinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Apatinib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Apatinib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Apatinib Value Chain Analysis
  2. 13.1.1 Apatinib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Apatinib Production Mode & Process
  6. 13.2 Apatinib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Apatinib Distributors
  9. 13.2.3 Apatinib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst